GSK shares rise after £1.7bn Zantac settlement pharma GSK shares have spiked today after the pharmaceutical giant agreed to pay as much as $2.2bn (£1.68bn) to settle lawsuits alleging one of its heartburn drugs had caused cancer. The discontinued version of the drug, Zantac, had triggered 80,000 lawsuits from 10 different law firms in the US and has hung over the FTSE 100 [...]
Fusion Antibodies: Pharma firm has ‘challenging’ year despite strong sales pipeline pharma Pharmaceutical company Fusion Antibodies said it had a “challenging” year but has seen its sales pipeline grow. Fusion posted audited revenue of £1.14m for the year ended March 2024, a 60 per cent drop from the £2.9m it reported in 2023. The company, which specialises in antibody discovery, engineering and supply for therapeutic drugs, said [...]
Horny Brew and Jerk Off Chicken on list of names rejected by Companies House Companies 'Reverse Cowgirl Riding School', 'Hashhunter Limited' and 'Beasts of Bondage' are three of the more than 700 company names that have recently been rejected by Companies House.
When the drugs don’t work: How the UK became addicted to antidepressants May 14, 2024 Almost one in four adults are being prescribed antidepressants, but they are not as effective as was once believed, writes Lucy Kenningham
Aquatics GB ‘extremely concerned’ about China positive drugs tests April 23, 2024 The country’s governing swimming body Aquatics GB has said it is “extremely concerned” by 23 Chinese athletes being cleared to compete at Tokyo 2020 despite testing positive for a banned substance before the Olympics. The swimmers tested positive for trimetazidine (TMZ), which is a heart medication used to prevent angina attacks, at a training camp [...]
420: Should you invest your green in the cannabis industry? April 20, 2024 The global cannabis industry is going through a growth spurt in April, with green shoots popping up across the world.